Bo‐Wei Wu

432 total citations
36 papers, 332 citations indexed

About

Bo‐Wei Wu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Bo‐Wei Wu has authored 36 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 29 papers in Cardiology and Cardiovascular Medicine and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in Bo‐Wei Wu's work include Cardiac electrophysiology and arrhythmias (27 papers), Ion channel regulation and function (26 papers) and Receptor Mechanisms and Signaling (8 papers). Bo‐Wei Wu is often cited by papers focused on Cardiac electrophysiology and arrhythmias (27 papers), Ion channel regulation and function (26 papers) and Receptor Mechanisms and Signaling (8 papers). Bo‐Wei Wu collaborates with scholars based in China, Sweden and United States. Bo‐Wei Wu's co-authors include Rong‐Rui Zhao, Michael Fu, Ji‐Min Cao, Qinghua Liu, Huirong Liu, Xiangli Cui, Tatsuto Kiyosue, Toshiaki Sato, Makoto Arita and Yuanyuan Lin and has published in prestigious journals such as PLoS ONE, British Journal of Pharmacology and Life Sciences.

In The Last Decade

Bo‐Wei Wu

34 papers receiving 327 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo‐Wei Wu China 12 219 216 59 48 26 36 332
Timothy P. Geisbuhler United States 9 138 0.6× 193 0.9× 34 0.6× 81 1.7× 29 1.1× 20 367
D Serena Italy 5 120 0.5× 208 1.0× 42 0.7× 79 1.6× 8 0.3× 6 349
Monika Skrzypiec‐Spring Poland 6 141 0.6× 92 0.4× 21 0.4× 86 1.8× 25 1.0× 15 305
Mathilde R. Rivaud Netherlands 10 292 1.3× 184 0.9× 35 0.6× 19 0.4× 9 0.3× 19 412
Jan Christian Reil Germany 10 214 1.0× 92 0.4× 23 0.4× 16 0.3× 19 0.7× 13 342
Julián Torres-Jácome Mexico 10 181 0.8× 135 0.6× 38 0.6× 12 0.3× 11 0.4× 15 305
Katz Am United States 10 308 1.4× 159 0.7× 43 0.7× 38 0.8× 37 1.4× 19 418
Changcong Cui China 9 218 1.0× 183 0.8× 20 0.3× 15 0.3× 9 0.3× 29 320
Marion Laudette France 8 126 0.6× 239 1.1× 35 0.6× 22 0.5× 8 0.3× 12 333
J Jehle Germany 9 92 0.4× 192 0.9× 63 1.1× 13 0.3× 9 0.3× 22 331

Countries citing papers authored by Bo‐Wei Wu

Since Specialization
Citations

This map shows the geographic impact of Bo‐Wei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo‐Wei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo‐Wei Wu more than expected).

Fields of papers citing papers by Bo‐Wei Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo‐Wei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo‐Wei Wu. The network helps show where Bo‐Wei Wu may publish in the future.

Co-authorship network of co-authors of Bo‐Wei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Bo‐Wei Wu. A scholar is included among the top collaborators of Bo‐Wei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo‐Wei Wu. Bo‐Wei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Qinghua, Jiaxing Sun, Pan Li, et al.. (2022). Tetramisole is a new IK1 channel agonist and exerts IK1‐dependent cardioprotective effects in rats. Pharmacology Research & Perspectives. 10(4). e00992–e00992. 5 indexed citations
2.
Lin, Yuanyuan, Qinghua Liu, Xiaojie Bai, et al.. (2020). Zacopride Exerts an Antiarrhythmic Effect by Specifically Stimulating the Cardiac Inward Rectifier Potassium Current in Rabbits: Exploration of a New Antiarrhythmic Strategy. Current Pharmaceutical Design. 26(44). 5746–5754. 4 indexed citations
3.
Liu, Qinghua, Xi Qiao, Lijun Zhang, et al.. (2019). IK1 Channel Agonist Zacopride Alleviates Cardiac Hypertrophy and Failure via Alterations in Calcium Dyshomeostasis and Electrical Remodeling in Rats. Frontiers in Pharmacology. 10. 929–929. 11 indexed citations
4.
Qiao, Xi, Li Zhang, Dongming Wang, et al.. (2019). IK1 channel agonist zacopride suppresses ventricular arrhythmias in conscious rats with healing myocardial infarction. Life Sciences. 239. 117075–117075. 13 indexed citations
5.
Zhang, Li, Ying Yang, Dongming Wang, et al.. (2017). The IK1/Kir2.1 channel agonist zacopride prevents and cures acute ischemic arrhythmias in the rat. PLoS ONE. 12(5). e0177600–e0177600. 16 indexed citations
6.
Liu, Enli, Jie Li, Shasha Shi, et al.. (2015). Sustained ERK activation-mediated proliferation inhibition of farrerol on human gastric carcinoma cell line by G0/G1-phase cell-cycle arrest. European Journal of Cancer Prevention. 25(6). 490–499. 24 indexed citations
7.
Tan, Xiaoqiu, Li Zhang, Bo‐Wei Wu, et al.. (2014). Multi-Walled Carbon Nanotubes Impair Kv4.2/4.3 Channel Activities, Delay Membrane Repolarization and Induce Bradyarrhythmias in the Rat. PLoS ONE. 9(7). e101545–e101545. 13 indexed citations
8.
Zhang, Li, Qinghua Liu, Ruiling Xu, et al.. (2013). Zacopride selectively activates the Kir2.1 channel via a PKA signaling pathway in rat cardiomyocytes. Science China Life Sciences. 56(9). 788–796. 17 indexed citations
9.
Liu, Qinghua, Xiaoli Li, Yanwu Xu, et al.. (2011). A Novel Discovery of IK1 Channel Agonist. Journal of Cardiovascular Pharmacology. 59(1). 37–48. 30 indexed citations
10.
Zhang, Xuanping, et al.. (2009). Dofetilide Enhances the Contractility of Rat Ventricular Myocytes via Augmentation of Na+–Ca2+ Exchange. Cardiovascular Drugs and Therapy. 23(3). 207–214. 12 indexed citations
11.
Wu, Bo‐Wei. (2008). Site specific antibody of Na/Ca exchanger stimulates Na/Ca exchanger current and has cross-reaction with Ca channel and Na pump. Zhongguo bingli shengli zazhi.
12.
Xu, Yanwu, Yan Li, Hui Liu, Ye Wu, & Bo‐Wei Wu. (2008). [Bioinformatics analysis of mouse adiponectin receptor-1 and its antibody preparation].. PubMed. 60(1). 156–60. 1 indexed citations
13.
Li, Xuewen, et al.. (2006). Differences of promethazine and terfenadine on ion channels in guinea pig ventricular myocytes. Chinese Medical Journal. 119(11). 944–947. 6 indexed citations
14.
Wang, Xiong, Bo‐Wei Wu, & Dongmei Wu. (2005). Effects of AMP579 and adenosine on L-type Ca2+ current in isolated rat ventricular myocytes. Acta Pharmacologica Sinica. 26(5). 559–562. 1 indexed citations
15.
Wu, Bo‐Wei. (2004). Effect of dofetilide on Na~+/Ca~(2+) exchange in ventricular myocytes of adult guinea pigs. Zhongguo yaolixue tongbao. 1 indexed citations
16.
Hao, Xiaojin, Sijin Li, Huirong Liu, & Bo‐Wei Wu. (2002). Immunization with beta(1)-adrenoreceptor peptide induces cardiomyopathy-like changes in rabbit hearts.. PubMed. 115(2). 170–4. 7 indexed citations
17.
18.
19.
Sato, Toshiaki, Bo‐Wei Wu, Tatsuto Kiyosue, & Makoto Arita. (1994). Effects of cibenzoline, a new class Ia antiarrhythmic drug, on various membrane ionic currents and action potentials of guinea-pig ventricular cells. Naunyn-Schmiedeberg s Archives of Pharmacology. 350(2). 167–73. 15 indexed citations
20.
Sato, Toshiaki, Bo‐Wei Wu, Sunao Nakamura, Tatsuto Kiyosue, & Makoto Arita. (1993). Cibenzoline inhibits diazoxide‐ and 2,4‐dinitrophenol‐activated ATP‐sensitive K+channels in guinea‐pig ventricular cells. British Journal of Pharmacology. 108(2). 549–556. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy P. Geisbuhler Breakdown of academic impact, for papers by D Serena Breakdown of academic impact, for papers by Monika Skrzypiec‐Spring Breakdown of academic impact, for papers by Mathilde R. Rivaud Breakdown of academic impact, for papers by Jan Christian Reil Breakdown of academic impact, for papers by Julián Torres-Jácome Breakdown of academic impact, for papers by Katz Am Breakdown of academic impact, for papers by Changcong Cui Breakdown of academic impact, for papers by Marion Laudette Breakdown of academic impact, for papers by J Jehle
Rankless by CCL
2026